Literature DB >> 10202873

Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study.

Y Abramov1, U Elchalal, J G Schenker.   

Abstract

OBJECTIVE: To assess the pulmonary manifestations of severe ovarian hyperstimulation syndrome (OHSS).
DESIGN: A retrospective nationwide 10-year multicenter study.
SETTING: Sixteen of 19 tertiary medical centers in Israel. PATIENT(S): All patients hospitalized at these centers for severe OHSS between January 1987 and December 1996. MAIN OUTCOME MEASURE(S): Clinical presentation, arterial blood gases on room air, and chest roentgenogram results. RESULT(S): Of 209 patients, 4% had lobar pneumonia, 2% had adult respiratory distress syndrome (ARDS), and 2% had pulmonary thromboembolism. Most patients had dyspnea, tachypnea, moderate hypoxemia, increased alveolar-arterial oxygen difference, hypocarbia, respiratory alkalosis, and metabolic compensation. The most common findings on chest roentgenogram were bilateral elevation of the diaphragm, pleural effusion, and pulmonary atelectasis. Patients with pulmonary thromboembolism, ARDS, and pneumonia presented with severe hypoxemia and alveolar-arterial oxygen difference and distinct radiographic findings. CONCLUSION(S): Severe OHSS is characterized by an extraparenchymal restrictive type of pulmonary dysfunction, attributed to intraabdominal or pleural fluid accumulation, which limits descent of the diaphragm and expansion of the thoracic cage. This may induce uncoordinated lung ventilation and atelectasis with subsequent ventilation-perfusion mismatch and hypoxemia. The clinical picture may deteriorate further because of pulmonary infection, pulmonary thromboembolism, or ARDS, all of which have distinct clinical, radiographic, and blood gas characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10202873     DOI: 10.1016/s0015-0282(98)00528-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

2.  Thoracic endometriosis unmasked by ovarian hyperstimulation for in vitro fertilization.

Authors:  Stephanie A C Halvorson; Mari A Ricker; Alan F Barker; Phillip E Patton; Rebecca A Harrison; Alan J Hunter
Journal:  J Gen Intern Med       Date:  2012-01-11       Impact factor: 5.128

3.  An immunohistochemical study in a fatality due to ovarian hyperstimulation syndrome.

Authors:  Vittorio Fineschi; Margherita Neri; Sabina Di Donato; Cristoforo Pomara; Irene Riezzo; Emanuela Turillazzi
Journal:  Int J Legal Med       Date:  2006-06-02       Impact factor: 2.686

Review 4.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

5.  Isolated bilateral pleural effusion as the sole manifestation of late onset ovarian hyperstimulation syndrome.

Authors:  Shalu Gupta; Balasubramaniam Sathya; Nabaneeta Padhy; Shankar Kundavi; Betty E Thomas; Thangam R Varma
Journal:  J Hum Reprod Sci       Date:  2009-07

6.  Symptomatic hemorrhagic pleural effusion: A rare presentation of ovarian hyperstimulation syndrome: A Case Report.

Authors:  Ali Alaraj
Journal:  Int J Health Sci (Qassim)       Date:  2013-11

7.  Ovarian hyperstimulation syndrome.

Authors:  Pratap Kumar; Sameer Farouk Sait; Alok Sharma; Mukesh Kumar
Journal:  J Hum Reprod Sci       Date:  2011-05

8.  Radiological illustration of spontaneous ovarian hyperstimulation syndrome.

Authors:  Kartik Mittal; Raj Koticha; Amit K Dey; Karan Anandpara; Rajat Agrawal; Madhva P Sarvothaman; Hemangini Thakkar
Journal:  Pol J Radiol       Date:  2015-04-28

9.  Effect of varying doses of tamoxifen on ovarian histopathology, serum VEGF, and endothelin 1 levels in ovarian hyperstimulation syndrome: an experimental study.

Authors:  Şehmus Pala; Remzi Atilgan; Zehra Sema Ozkan; Salih Burçin Kavak; Nevin Ilhan; Nusret Akpolat; Ekrem Sapmaz
Journal:  Drug Des Devel Ther       Date:  2015-03-24       Impact factor: 4.162

10.  The influence of obesity on incidence of complications in patients hospitalized with ovarian hyperstimulation syndrome.

Authors:  Rachel S Mandelbaum; Liat Bainvoll; Caroline J Violette; Meghan B Smith; Shinya Matsuzaki; Maximilian Klar; Jacqueline R Ho; Kristin A Bendikson; Richard J Paulson; Koji Matsuo
Journal:  Arch Gynecol Obstet       Date:  2021-07-09       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.